Arizona State Retirement System’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$885K Buy
10,510
+1,747
+20% +$127K 0.01% 1157
2025
Q4
$661K Buy
8,763
+2,161
+33% +$136K ﹤0.01% 1330
2025
Q3
$262K Buy
6,602
+114
+2% +$4.35K ﹤0.01% 1847
2025
Q2
$282K Buy
6,488
+36
+0.6% +$1.37K ﹤0.01% 1758
2025
Q1
$241K Sell
6,452
-65
-1% -$2.51K ﹤0.01% 1799
2024
Q4
$295K Buy
6,517
+960
+17% +$49K ﹤0.01% 1765
2024
Q3
$326K Sell
5,557
-436
-7% -$20.9K ﹤0.01% 1716
2024
Q2
$236K Buy
5,993
+258
+4% +$12.5K ﹤0.01% 1819
2024
Q1
$381K Buy
+5,735
New +$250K ﹤0.01% 1592

Other funds holding APGE

Arizona State Retirement System's APGE Position: Q1 2026 in Review

Arizona State Retirement System increased its Apogee Therapeutics (APGE) stake by 20% in Q1 2026, buying an estimated $127K and bringing the position to 10,510 shares worth $885K. The position accounts for 0.01% of the portfolio, ranked #1157.

Arizona State Retirement System first reported a position in APGE in Q1 2024 and has held it in 9 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • Arizona State Retirement System held 10,510 shares of Apogee Therapeutics worth $885K as of Q1 2026.
  • Arizona State Retirement System bought 1,747 Apogee Therapeutics shares in Q1 2026, an estimated $127K.
  • Apogee Therapeutics made up 0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1157 holding.
  • Arizona State Retirement System first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.